Northwestern Medicine
Coverage of Northwestern Medicine in the Nexus archive.
- Simple sitting change linked to lower risk of cancer death, study finds
A study led by the University of Glasgow found that interrupting prolonged sitting with physical activity reduces cancer death risk. Participants who broke up sedentary periods with light, moderate, or vigorous activity saw risk reductions of 12%, 8%, and 22% respectively when replacing one hour or portions of sitting. The observational study tracked 91,292 UK participants over 12 years using movement-tracking devices.
- Rare transplant gives Stage 4 lung cancer patients a second chance at life — a Capitol Hill man is proof
David Peterson, a Stage 4 lung cancer patient, underwent a double lung transplant at Northwestern Medicine's DREAM program, the only U.S. hospital performing this treatment for such cases, after traditional therapies failed. The procedure, inspired by pandemic-era lung transplant techniques, saved his life.
- Age is just a number for 87-year-old Northwestern Medicine transplant recipient
An 87-year-old woman named Sheila Perry received a kidney transplant at Northwestern Medicine, with her care team emphasizing her vitality. Dr. Vinayak Rohan, a Northwestern Medicine transplant surgeon, described her as 'full of life.'
- Understanding ADHD, autism and other conditions in older adults
Many older adults in the U.S. have lived with undiagnosed neurodivergent conditions like ADHD, autism, dyslexia, or OCD, which can become more challenging with aging. Experts highlight the need to distinguish these lifelong traits from dementia and emphasize understanding neurodiversity to provide better support for aging individuals.
- Understanding ADHD, autism and other conditions in older adults
The article discusses challenges faced by neurodivergent older adults in the U.S., such as undiagnosed ADHD, autism, or dyslexia, as aging disrupts routines and coping strategies. It emphasizes the importance of distinguishing neurodiversity from dementia and highlights generational gaps in diagnosing these conditions, which were often overlooked in older generations.
- Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it
Abridge, a health tech startup, has partnered with NVIDIA and Eli Lilly to develop an AI-native clinician intelligence platform that streamlines clinical documentation, billing, and pharmaceutical trial screening. The platform, used by over 300 health systems, captures real-time patient-clinician conversations and has raised $1.1 billion, including a $316 million Series E extension. NVIDIA is co-developing a foundation model for clinical dialogue, while Eli Lilly aligns with its AI-driven healthcare initiatives.